Living Proof and Valeant Pharmaceuticals team up for skincare venture

US-based beauty company Living Proof has signed a global joint venture with Canada-based Valeant Pharmaceuticals International to develop, distribute and sell aesthetic dermatology products. The transaction is worth over $75m, according to Living Proof. Some 60% of profits will go...
Read the full article now!
Subscribe